These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21536741)

  • 1. Langerhans cells are negative regulators of the anti-Leishmania response.
    Kautz-Neu K; Noordegraaf M; Dinges S; Bennett CL; John D; Clausen BE; von Stebut E
    J Exp Med; 2011 May; 208(5):885-91. PubMed ID: 21536741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes.
    Brewig N; Kissenpfennig A; Malissen B; Veit A; Bickert T; Fleischer B; Mostböck S; Ritter U
    J Immunol; 2009 Jan; 182(2):774-83. PubMed ID: 19124720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dectin-1 Positive Dendritic Cells Expand after Infection with
    Zimara N; Chanyalew M; Aseffa A; van Zandbergen G; Lepenies B; Schmid M; Weiss R; Rascle A; Wege AK; Jantsch J; Schatz V; Brown GD; Ritter U
    Front Immunol; 2018; 9():263. PubMed ID: 29535708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRF4 in dendritic cells inhibits IL-12 production and controls Th1 immune responses against Leishmania major.
    Akbari M; Honma K; Kimura D; Miyakoda M; Kimura K; Matsuyama T; Yui K
    J Immunol; 2014 Mar; 192(5):2271-9. PubMed ID: 24489086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
    Ritter U; Meissner A; Scheidig C; Körner H
    Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection.
    Iezzi G; Fröhlich A; Ernst B; Ampenberger F; Saeland S; Glaichenhaus N; Kopf M
    J Immunol; 2006 Jul; 177(2):1250-6. PubMed ID: 16818784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new view on cutaneous dendritic cell subsets in experimental leishmaniasis.
    Ritter U; Osterloh A
    Med Microbiol Immunol; 2007 Mar; 196(1):51-9. PubMed ID: 16786361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility.
    Nagase H; Jones KM; Anderson CF; Noben-Trauth N
    J Immunol; 2007 Aug; 179(4):2435-44. PubMed ID: 17675505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to sand fly salivary protein LJM11 modulates host response to vector-transmitted leishmania conferring ulcer-free protection.
    Gomes R; Oliveira F; Teixeira C; Meneses C; Gilmore DC; Elnaiem DE; Kamhawi S; Valenzuela JG
    J Invest Dermatol; 2012 Dec; 132(12):2735-43. PubMed ID: 22739793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Regulatory T Cells in Leishmania major‒Infected BALB/c Mice Does Not Require Langerin+ Dendritic Cells.
    Lukas D; Dietze-Schwonberg K; Kautz-Neu K; Lorenz B; Yogev N; Clausen BE; von Stebut E
    J Invest Dermatol; 2021 Apr; 141(4):936-938. PubMed ID: 32941919
    [No Abstract]   [Full Text] [Related]  

  • 11. Langerhans cells promote early germinal center formation in response to Leishmania-derived cutaneous antigens.
    Zimara N; Florian C; Schmid M; Malissen B; Kissenpfennig A; Männel DN; Edinger M; Hutchinson JA; Hoffmann P; Ritter U
    Eur J Immunol; 2014 Oct; 44(10):2955-67. PubMed ID: 25070244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.
    Soto M; Corvo L; Garde E; Ramírez L; Iniesta V; Bonay P; Gómez-Nieto C; González VM; Martín ME; Alonso C; Coelho EA; Barral A; Barral-Netto M; Iborra S
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003751. PubMed ID: 25955652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
    Anderson CF; Mendez S; Sacks DL
    J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th1 concomitant immune response mediated by IFN-γ protects against sand fly delivered Leishmania infection: Implications for vaccine design.
    Seyed N; Rafati S
    Cytokine; 2021 Nov; 147():155247. PubMed ID: 32873468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research in practice: Different dendritic cell types in skin with various functions - important implications for intradermal vaccines.
    von Stebut E
    J Dtsch Dermatol Ges; 2011 Jul; 9(7):506-9. PubMed ID: 21539709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with live Leishmania major and CpG DNA promotes interleukin-2 production by dermal dendritic cells and NK cell activation.
    Laabs EM; Wu W; Mendez S
    Clin Vaccine Immunol; 2009 Nov; 16(11):1601-6. PubMed ID: 19776191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies.
    Okwor I; Uzonna J
    Immunol Res; 2008; 41(2):123-36. PubMed ID: 18389179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania major-infected murine langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis.
    von Stebut E; Belkaid Y; Nguyen BV; Cushing M; Sacks DL; Udey MC
    Eur J Immunol; 2000 Dec; 30(12):3498-506. PubMed ID: 11093169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania major p27 gene knockout as a novel live attenuated vaccine candidate: Protective immunity and efficacy evaluation against cutaneous and visceral leishmaniasis in BALB/c mice.
    Elikaee S; Mohebali M; Rezaei S; Eslami H; Khamesipour A; Keshavarz H; Eshraghian MR
    Vaccine; 2019 May; 37(24):3221-3228. PubMed ID: 31047672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice.
    Dioszeghy V; Mondoulet L; Laoubi L; Dhelft V; Plaquet C; Bouzereau A; Dupont C; Sampson H
    Front Immunol; 2018; 9():1951. PubMed ID: 30233572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.